Literature DB >> 29707631

Polymer Microneedle Mediated Local Aptamer Delivery for Blocking the Function of Vascular Endothelial Growth Factor.

James Coyne1, Brandon Davis1, David Kauffman1, Nan Zhao1, Yong Wang1.   

Abstract

Overexpression of proteins in the body can cause severe diseases and other physiological disturbances. The development of protein blockers and local delivery systems would offer opportunities for addressing the health problems caused by protein overexpression. Nucleic acid aptamers are an emerging class of ligands with the potential to block proteins effectively; however, little effort has been made in developing polymer systems for local aptamer delivery. In this work, polymer microneedles capable of delivering DNA aptamers locally to inhibit the function of vascular endothelial growth factor (VEGF) were developed and studied. The presence of anti-VEGF aptamer in the polymer matrix did not change the apparent mechanical strength of the microneedles. Once in contact with a physiological solution, the polymer microneedles quickly dissolved, generating a high concentration of anti-VEGF aptamer in the surrounding local microenvironment. Aptamer delivery by way of dissolving polymer microneedles in a tissue phantom reduced VEGF-mediated endothelial cell tube formation. Thus, aptamer-loaded polymer microneedles hold great potential as a therapeutic tool for the treatment of human diseases resulting from protein overexpression.

Entities:  

Keywords:  Protein overexpression; aptamer; drug delivery; hydrogel; microneedles

Year:  2017        PMID: 29707631      PMCID: PMC5912260          DOI: 10.1021/acsbiomaterials.7b00718

Source DB:  PubMed          Journal:  ACS Biomater Sci Eng        ISSN: 2373-9878


  55 in total

1.  VARIATIONS IN AFFINITIES OF ANTIBODIES DURING THE IMMUNE RESPONSE.

Authors:  H N EISEN; G W SISKIND
Journal:  Biochemistry       Date:  1964-07       Impact factor: 3.162

Review 2.  Monoclonal antibodies as innovative therapeutics.

Authors:  Janice M Reichert
Journal:  Curr Pharm Biotechnol       Date:  2008-12       Impact factor: 2.837

Review 3.  Thrombin binding aptamer, more than a simple aptamer: chemically modified derivatives and biomedical applications.

Authors:  Anna Avino; Carme Fabrega; Maria Tintore; Ramon Eritja
Journal:  Curr Pharm Des       Date:  2012       Impact factor: 3.116

Review 4.  Affinity enhancement of antibodies: how low-affinity antibodies produced early in immune responses are followed by high-affinity antibodies later and in memory B-cell responses.

Authors:  Herman N Eisen
Journal:  Cancer Immunol Res       Date:  2014-05       Impact factor: 11.151

5.  Biomedical Applications of Biodegradable Polymers.

Authors:  Bret D Ulery; Lakshmi S Nair; Cato T Laurencin
Journal:  J Polym Sci B Polym Phys       Date:  2011-06-15

6.  Overexpression of vascular endothelial growth factor (VEGF) in the retinal pigment epithelium leads to the development of choroidal neovascularization.

Authors:  K Spilsbury; K L Garrett; W Y Shen; I J Constable; P E Rakoczy
Journal:  Am J Pathol       Date:  2000-07       Impact factor: 4.307

7.  Discovering small molecule ligands of vascular endothelial growth factor that block VEGF-KDR binding using label-free microarray-based assays.

Authors:  James P Landry; Yiyan Fei; Xiangdong Zhu; Yaohuang Ke; Guoliang Yu; Pierre Lee
Journal:  Assay Drug Dev Technol       Date:  2013-06       Impact factor: 1.738

8.  Coated microneedles for drug delivery to the eye.

Authors:  Jason Jiang; Harvinder S Gill; Deepta Ghate; Bernard E McCarey; Samir R Patel; Henry F Edelhauser; Mark R Prausnitz
Journal:  Invest Ophthalmol Vis Sci       Date:  2007-09       Impact factor: 4.799

9.  Binding and neutralization of vascular endothelial growth factor (VEGF) and related ligands by VEGF Trap, ranibizumab and bevacizumab.

Authors:  Nicholas Papadopoulos; Joel Martin; Qin Ruan; Ashique Rafique; Michael P Rosconi; Ergang Shi; Erica A Pyles; George D Yancopoulos; Neil Stahl; Stanley J Wiegand
Journal:  Angiogenesis       Date:  2012-06       Impact factor: 9.596

Review 10.  Nucleic Acid Ligands With Protein-like Side Chains: Modified Aptamers and Their Use as Diagnostic and Therapeutic Agents.

Authors:  John C Rohloff; Amy D Gelinas; Thale C Jarvis; Urs A Ochsner; Daniel J Schneider; Larry Gold; Nebojsa Janjic
Journal:  Mol Ther Nucleic Acids       Date:  2014-10-07       Impact factor: 10.183

View more
  5 in total

1.  Macroporous Hydrogels for Stable Sequestration and Sustained Release of Vascular Endothelial Growth Factor and Basic Fibroblast Growth Factor Using Nucleic Acid Aptamers.

Authors:  Lidya Abune; Nan Zhao; Jinping Lai; Benjamin Peterson; Spencer Szczesny; Yong Wang
Journal:  ACS Biomater Sci Eng       Date:  2019-04-17

2.  Pathogen-specific antimicrobials engineered de novo through membrane-protein biomimicry.

Authors:  Andrew W Simonson; Agustey S Mongia; Matthew R Aronson; John N Alumasa; Dennis C Chan; Atip Lawanprasert; Michael D Howe; Adam Bolotsky; Tapas K Mal; Christy George; Aida Ebrahimi; Anthony D Baughn; Elizabeth A Proctor; Kenneth C Keiler; Scott H Medina
Journal:  Nat Biomed Eng       Date:  2021-01-04       Impact factor: 25.671

3.  Potent anti-angiogenesis and anti-tumour activity of pegaptanib-loaded tetrahedral DNA nanostructure.

Authors:  Xueping Xie; Yuxin Zhang; Wenjuan Ma; Xiaoru Shao; Yuxi Zhan; Chenchen Mao; Bofeng Zhu; Yi Zhou; Hu Zhao; Xiaoxiao Cai
Journal:  Cell Prolif       Date:  2019-07-31       Impact factor: 6.831

Review 4.  Current trends in polymer microneedle for transdermal drug delivery.

Authors:  Khater Ahmed Saeed Al-Japairai; Syed Mahmood; Samah Hamed Almurisi; Jayarama Reddy Venugopal; Ayah Rebhi Hilles; Motia Azmana; Subashini Raman
Journal:  Int J Pharm       Date:  2020-07-30       Impact factor: 5.875

Review 5.  Smart Microneedles for Therapy and Diagnosis.

Authors:  Xiaoxuan Zhang; Yuetong Wang; Junjie Chi; Yuanjin Zhao
Journal:  Research (Wash D C)       Date:  2020-12-18
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.